Home > Healthcare > Pharmaceuticals > Finished Drug Form > Retinal Biologics Market

Retinal Biologics Market Share

  • Report ID: GMI4429
  • Published Date: Apr 2024
  • Report Format: PDF
 Download Free Sample

Retinal Biologics Market Share

The retinal biologics industry is characterized by the presence of leading pharmaceutical and biopharmaceutical companies. The key market players include F-Hoffman La Roche Ltd., Novartis AG, and AbbVie Inc. which are focused on developing improved treatments, such as longer-acting formulations and innovative therapies. Market players compete on factors like efficacy, safety, patient convenience, and cost-effectiveness.
 

Retinal Biologics Market Companies

Prominent players operating in the retinal biologics industry include:

  • AbbVie Inc.
  • Amgen Inc.
  • Janssen Pharmaceuticals (Johnson & Johnson)
  • F-Hoffman La Roche Ltd.
  • Oxurion NV
  • Novartis AG
  • MeiraGTx Limited
  • Regeneron Pharmaceuticals Inc.
  • OncoGene Pharmaceuticals
  • SemaThera Inc.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global retinal biologics market was valued at USD 23.4 billion in 2023 and is anticipated grow at 8.2% CAGR during 2024-2032, attributed to the increasing prevalence of retinal diseases, particularly age-related macular degeneration (AMD) and diabetic retinopathy.

The macular degeneration segment held 40.1% of the market share in 2023 owing to the growing elderly population globally.

North America retinal biologics market was valued at USD 9.7 billion and is predicted to grow at 8% CAGR during 2024-2032, attributed to the advanced healthcare infrastructure and high prevalence of retinal diseases.

AbbVie Inc., Amgen Inc., Janssen Pharmaceuticals (Johnson & Johnson), F-Hoffman La Roche Ltd., Oxurion NV, Novartis AG, MeiraGTx Limited, Regeneron Pharmaceuticals Inc., OncoGene Pharmaceuticals and SemaThera In

Retinal Biologics Market Scope

  • Retinal Biologics Market Size
  • Retinal Biologics Market Trends
  • Retinal Biologics Market Analysis
  • Retinal Biologics Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2023
    • Companies covered: 10
    • Tables & Figures: 206
    • Countries covered: 22
    • Pages: 114
     Download Free Sample
    ×
    Get a free sample of Retinal Biologics Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.